Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neil Hayes

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Nucleic Acids Research|March 13, 2018
The association between copy number aberration, DNA methylation and gene expression in tumor samplesWei Sun, Paul Bunn, Chong Jin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 14, 2018
Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) ApproachNirali M Patel, Heejoon Jo, David A Eberhard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell CarcinomaJeremiah Holt, Vonn Walter, Xiaoying Yin, et al.
Pharmacology Research & Perspectives|December 3, 2019
Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studiesRaymond P Perez, Eric Chen, J Thaddeus Beck, et al.
Oral Oncology|August 18, 2018
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neckJared Weiss, Jill Gilbert, Allison Mary Deal, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation SequencingNathan D Montgomery, Joel S Parker, David A Eberhard, et al.
Molecular Carcinogenesis|March 23, 2022
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cellsManjul Rana, Rita Kansal, Mehdi Chaib, et al.
Oral Oncology|March 9, 2022
Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinomaSiddharth Sheth, Jill Gilbert, Allison Mary Deal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Nucleic Acids Research|March 13, 2018
The association between copy number aberration, DNA methylation and gene expression in tumor samplesWei Sun, Paul Bunn, Chong Jin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 14, 2018
Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) ApproachNirali M Patel, Heejoon Jo, David A Eberhard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell CarcinomaJeremiah Holt, Vonn Walter, Xiaoying Yin, et al.
Pharmacology Research & Perspectives|December 3, 2019
Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studiesRaymond P Perez, Eric Chen, J Thaddeus Beck, et al.
Oral Oncology|August 18, 2018
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neckJared Weiss, Jill Gilbert, Allison Mary Deal, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation SequencingNathan D Montgomery, Joel S Parker, David A Eberhard, et al.
Molecular Carcinogenesis|March 23, 2022
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cellsManjul Rana, Rita Kansal, Mehdi Chaib, et al.
Oral Oncology|March 9, 2022
Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinomaSiddharth Sheth, Jill Gilbert, Allison Mary Deal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Pageof 3